Back to Search
Start Over
Insights from compassionate use of tocilizumab for COVID‐19 to inform appropriate design of randomised controlled trials
- Source :
- British Journal of Clinical Pharmacology
- Publication Year :
- 2020
- Publisher :
- John Wiley and Sons Inc., 2020.
- Subjects :
- Pharmacology
Compassionate Use Trials
2019-20 coronavirus outbreak
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
business.industry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
MEDLINE
Compassionate Use
COVID-19
Antibodies, Monoclonal, Humanized
COVID-19 Drug Treatment
chemistry.chemical_compound
Tocilizumab
Treatment Outcome
chemistry
Research Design
Medicine
Humans
Pharmacology (medical)
business
Intensive care medicine
Cytokine Release Syndrome
Letter to the Editor
Randomized Controlled Trials as Topic
Subjects
Details
- Language :
- English
- ISSN :
- 13652125 and 03065251
- Database :
- OpenAIRE
- Journal :
- British Journal of Clinical Pharmacology
- Accession number :
- edsair.doi.dedup.....fa7ecbbfda254fe94d9f78fb15c1ec79